Sharma Panna Insider Trades

Insider Trading History

Track insider trading activity for Sharma Panna. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lantern Pharma
Lantern Pharma LTRN
President And CEO
Holding Value $265k 70,000 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$305k 70,000 shares
$4.35
$3.79
Lantern Pharma
Lantern Pharma LTRN
President And CEO
Holding Value $379k 100,000 shares
Last Trade
Aug 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$546k 100,000 shares
$5.46
$3.79
Lantern Pharma
Lantern Pharma LTRN
President & CEO
Holding Value $290k 76,628 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 76,628 shares
$14.68
$3.79
Lantern Pharma
Lantern Pharma LTRN
President & CEO
Holding Value $0 0 shares
Last Trade
Jun 15, 2020 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.15M 76,628 shares
$15.00
$3.79
Lantern Pharma
Lantern Pharma LTRN
CEO & President
Holding Value $290k 76,628 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15M 76,628 shares
$15.00
$3.79
Lantern Pharma
Lantern Pharma LTRN
CEO & President
Holding Value $0 0 shares
Last Trade
Jun 10, 2020 Sale
No data
No data
$3.79
Vyant Bio
Vyant Bio VYNT
Chief Executive Officer
Holding Value $38.8k 200,000 shares
Last Trade
Feb 22, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15M 200,000 shares
$75.00
$0.19
Vyant Bio
Vyant Bio VYNT
Chief Executive Officer
Holding Value $29.6k 152,500 shares
Last Trade
Mar 17, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$38.6k 500 shares
$77.10
$0.19
Vyant Bio
Vyant Bio VYNT
Chief Executive Officer
Holding Value $29.5k 152,000 shares
Last Trade
Mar 16, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$72.6k 1,000 shares
$72.60
$0.19
Vyant Bio
Vyant Bio VYNT
Chief Executive Officer
Holding Value $29.3k 151,000 shares
Last Trade
Mar 15, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$77.7k 1,000 shares
$77.70
$0.19
Vyant Bio
Vyant Bio VYNT
Chief Executive Officer
Holding Value $48.5k 250,000 shares
Last Trade
Dec 11, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.3M 250,000 shares
$189.00
$0.19
Vyant Bio
Vyant Bio VYNT
Chief Executive Officer
Holding Value $29.1k 150,000 shares
Last Trade
Dec 11, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9M 100,000 shares
$189.00
$0.19
Vyant Bio
Vyant Bio VYNT
President & CEO
Holding Value $9.7k 50,000 shares
Last Trade
May 22, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.6M 50,000 shares
$351.00
$0.19
Vyant Bio
Vyant Bio VYNT
Chief Executive Officer
Holding Value $38.8k 200,000 shares
Last Trade
Oct 10, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$102M 200,000 shares
$509.40
$0.19
Vyant Bio
Vyant Bio VYNT
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Apr 04, 2013 Sale
No data
No data
$0.19
Vyant Bio
Vyant Bio VYNT
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Apr 01, 2010 Sale
No data
No data
$0.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up